Adagrasib is made to target KRAS G12C mutations. These mutations are quite common in Non-Small Cell Lung Cancer (NSCLC). You can get this drug in 200 mg tablet form.
and For people with NSCLC and the KRAS G12C mutation, the go-to dose is 600 mg, taken twice a day. It’s okay to take it with or without food. It comes in a handy 180-tablet bottle, too.